Aura Biosciences, Inc., a clinical-stage biotech company that develops a new class of virus-like drug conjugate therapies for multiple cancer indications, announced that AU-011, the…
October 31, 2024
Aura Biosciences, Inc., a clinical-stage biotech company that develops a new class of virus-like drug conjugate therapies for multiple cancer indications, announced that AU-011, the…